![[Article Title]](https://media.americanpharmaceuticalreview.com/m/28/article/617585-134x100.jpg)
Cell therapy products show great potential in regenerative medicine but are vulnerable to microbial contamination due to complex manufacturing processes. Traditional sterility testing requires a 14-day culture, delaying the release of time-sensitive therapies. USP chapter <1071> highlights rapid alternatives like qPCR, which enables microorganism detection within hours.
Download this application note to discover how the Applied Biosystems™ SteriSEQ™ Rapid Sterility Testing Kit, powered by TaqMan™ chemistry, delivers actionable sterility results in just 5 hours for fast and reliable cell therapy testing.